(c) 2024 PillSync.com

atorvastatin calcium tablet film coated

1 INDICATIONS AND USAGE Atorvastatin calcium tablets are indicated: • To reduce the risk of: o Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD o MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD o Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD • As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: o Adults with primary hyperlipidemia. o Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH). • As an adjunct to diet for the treatment of adults with: o Primary dysbetalipoproteinemia o Hypertriglyceridemia Atorvastatin calcium tablets are an HMG-CoA reductase inhibitor (statin) indicated ( 1 ): • To reduce the risk of: o Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD. o MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD. o Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD. • As an adjunct to diet to reduce low-density lipoprotein (LDL-C) in: o Adults with primary hyperlipidemia. o Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to other LDL-C-lowering therapies to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia. • As an adjunct to diet for the treatment of adults with: o Primary dysbetalipoproteinemia. o Hypertriglyceridemia.

msn laboratories private limited


11 months ago OVAL WHITE 3 MA atorvastatin calcium tablet film coated

OVAL WHITE 3 MA

11 months ago OVAL WHITE 3 MA atorvastatin calcium tablet film coated

3 MA OVAL WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING

ATORVASTATIN CALCIUM tablets, USP are supplied as follows: Strength How Supplied NDC Tablet Description 10 mg of atorvastatin bottles of 30 69539-093-30 white coloured, oval shaped, biconvex, film-coated tablets with "MA" on one side and "1" on other side. bottles of 90 69539-093-90 bottles of 500 69539-093-05 bottles of 1000 69539-093-99 20 mg of atorvastatin bottles of 30 69539-094-30 20 mg of atorvastatin: white coloured, oval shaped, biconvex, film-coated tablets with "MA" on one side and "2" on other side. bottles of 90 69539-094-90 bottles of 500 69539-094-05 bottles of 1000 69539-094-99 40 mg of atorvastatin bottles of 30 69539-095-30 40 mg of atorvastatin: white coloured, oval shaped, biconvex, film-coated tablets with "MA" on one side and "3" on other side. bottles of 90 69539-095-90 bottles of 500 69539-095-05 bottles of 1000 69539-095-99 80 mg of atorvastatin bottles of 30 69539-096-30 80 mg of atorvastatin: white coloured, oval shaped, biconvex, film-coated tablets with "MA" on one side and "4" on other side. bottles of 90 69539-096-90 bottles of 500 69539-096-05 bottles of 1000 69539-096-99 Storage Store at controlled room temperature 20º to 25ºC (68º to 77ºF).


More pills like OVAL 3 MA

Related Pills

atorvastatin calcium 10 mg

MSN LABORATORIES PRIVATE LIMITED

atorvastatin 40 mg

msn laboratories private limited












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site